The Pharmaceutical Society of Australia (PSA) welcomed the release of the first issue paper from the Unleashing the Potential of our Health Workforce Scope of Practice Review (the Cormack Review) last week.
PSA National President A/Prof Fei Sim FPS said that the paper highlights both the urgent and the long-term need for pharmacists to contribute to improving access to care and medicine safety through working to their full and top of scope.
“The Cormack Review’s first issues paper confirms that inconsistent regulations, unnecessary restrictions on practice, and siloed workforces are having a detrimental impact on patients,” A/Prof Sim said.
“As pharmacists, we welcome the paper as the first step in the review process, however, we need to now look towards solutions.
“PSA is making the case for solutions that recognise the potential of pharmacists as vital members of the healthcare team.
“PSA sees a future where community pharmacies are supported and funded to fulfill their primary care role as urgent care clinics where pharmacists can triage, manage and consult on a range of acute common ailments.
“This includes the ability to prescribe PBS medicines, harnessing the accessibility of pharmacists to deliver timely, cost-effective care – dramatically reducing patients’ out-of-pocket costs.
“We see a future where pharmacists are embedded in multidisciplinary health care teams wherever medicines are prescribed, supplied, administered, or reviewed, and where pharmacists are utilised to support patients in managing chronic health conditions – whether that is a medicine or a referral to another healthcare provider.
“To achieve these aims, regulatory, financial and systems barriers must be recognised and removed, and only until then, we can see the full potential of pharmacists unleashed.
“As the next phase of consultation begins, we are continuing to advocate directly to government for the future of our profession and importantly, the future of our patients.”
A/Prof Fei Sim currently sits on the Cormack Review’s Expert Advisory Committee, representing the pharmacy profession.
